![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessDeciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses
Cellular heterogeneity is a major cause of treatment resistance in cancer. Despite recent advances in single-cell genomic and transcriptomic sequencing, it remains difficult to relate measured molecular profil...
-
Article
Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells
A Correction to this paper has been published: https://doi.org/10.1038/s41586-021-03388-4.
-
Article
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells
Interferon-induced transmembrane protein 3 (IFITM3) has previously been identified as an endosomal protein that blocks viral infection1–3. Here we studied clinical cohorts of patients with B cell leukaemia and ly...
-
Article
Signalling input from divergent pathways subverts B cell transformation
Malignant transformation of cells typically involves several genetic lesions, whose combined activity gives rise to cancer1. Here we analyse 1,148 patient-derived B-cell leukaemia (B-ALL) samples, and find that i...
-
Article
Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors
In Fig. 3c of this Letter, the the effects of CRISPR–Cas9-mediated deletion of NR3C1, TXNIP and CNR2 in patient-derived B-lineage leukaemia cells were shown. For curves depicting NR3C1 (left graph), data s for TX...
-
Reference Work Entry In depth
Protein Farnesyltransferase
-
Article
Metabolic gatekeeper function of B-lymphoid transcription factors
The B-lymphoid transcription factors PAX5 and IKZF1 restrict the supply of glucose and energy to B cells to levels that are not enough to fuel a driver-oncogene, thereby acting as tumour suppressors and sensit...
-
Article
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
As opposed to its tumor suppressor role in other cancers, PTEN inhibition in pre-B ALL is therapeutically effective and triggers cell death.
-
Article
Open AccessIn vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
Lung cancer is the leading cause of cancer-related mortality. Therapies against non-small cell lung cancer (NSCLC) are particularly needed, as this type of cancer is relatively insensitive to chemotherapy and ...
-
Reference Work Entry In depth
Protein Farnesyltransferase